Type 2 diabetes trials in Romania
10 of 11 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleEASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Where
- Alba Iulia, Baia Mare, Bucharest, Buzău, Galati, Jassi, Oradea, Pitesti, Târgu Mureş, Timisoara, Timișoara
- Age
- 18 years and over
- People
- 11,800 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07064473 · EU 2025-521188-11-00 - Phase 3Not yet taking people in RomaniaA Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Diet and Exercise
- Where
- Bucharest, Oradea, Reghin, Sibiu, Târgu Mureş
- Age
- 18 years and over
- People
- 200 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07931495 · EU 2026-525470-18-00 - Phase 3Not yet taking people in RomaniaAMBITION 3: A Research Study Investigating How Well Zenagamtide at Higher Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide in People With Type 2 Diabetes Treated With Metformin, SGLT2i, or Both
- Where
- Baia Mare, Brasov, Bucharest, Oradea, Paşcani, Pitesti, Ploiesti, Ploieşti
- Age
- 18 years and over
- People
- 1,200 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07931573 · EU 2026-525472-26-00 - Phase 3Taking peopleA Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Where
- Brasov, Bucharest, Cluj-Napoca, Craiova, Jassi, Ploiesti, Timisoara
- Age
- 18 years and over
- People
- 1,600 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07351058 · EU 2025-523106-32-00 - Phase 3Taking peopleA Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- Where
- Brasov, Bucharest, Mangalia, Oradea, Satu Mare, Targoviste, Targu Mures, Timisoara
- Age
- 18 years and over
- People
- 900 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07392190 · EU 2025-523659-73-00 - Phase 3Taking peopleA Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
- Where
- Baia Mare, Brasov, Bucharest, Craiova, Galați, Mangalia, Oradea, Satu Mare
- Age
- 18 years and over
- People
- 1,000 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07881458 · EU 2026-527230-31-00 - Phase 3Not yet taking people in RomaniaA Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk
- Where
- Bacau, Baia Mare, Brasov, Bucharest, Craiova, Galati, Mangalia, Satu Mare, Targoviste
- Age
- 45 years to 64 years
- People
- 3,000 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07900633 · EU 2026-525919-14-00 - Phase 4Taking peopleEffect of Low Protein Diet on Top of Dapagliflozin on Chronic Kidney Disease in Patients With Type 2 Diabetes Mellitus
- Where
- Bucharest
- Age
- 18 years and over
- People
- 200
- Run by
- Anemia Working Group Romania
See details and how to joinNCT06281899 - Phase 2Taking peopleA Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
- Where
- Brasov, Bucharest, Craiova, Galati, Satu Mare, Timisoara
- Age
- 18 years to 75 years
- People
- 300 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07668388 · EU 2026-525465-42-00 - Phase 3Taking peopleA Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
- Where
- Baia Mare, Brasov, Bucharest, Buzău, Craiova, Oradea, Pitesti, Târgu Mureş, Timisoara
- Age
- 18 years and over
- People
- 2,500 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07564414 · EU 2025-522488-14-00